Size-transformable nanotherapeutics for cancer therapy

Teng Ma, Tuyen Ba Tran, Ethan Lin, Stephanie Hunt, Riley Haveman, Kylie Castro, Jianqin Lu

Research output: Contribution to journalReview articlepeer-review

Abstract

The size of nanodrugs plays a crucial role in shaping their chemical and physical characteristics, consequently influencing their therapeutic and diagnostic interactions within biological systems. The optimal size of nanomedicines, whether small or large, offers distinct advantages in disease treatment, creating a dilemma in the selection process. Addressing this challenge, size-transformable nanodrugs have surfaced as a promising solution, as they can be tailored to entail the benefits associated with both small and large nanoparticles. In this review, various strategies are summarized for constructing size-transformable nanosystems with a focus on nanotherapeutic applications in the field of biomedicine. Particularly we highlight recent research developments in cancer therapy. This review aims to inspire researchers to further develop various toolboxes for fabricating size-transformable nanomedicines for improved intervention against diverse human diseases.

Original languageEnglish (US)
Pages (from-to)834-851
Number of pages18
JournalActa Pharmaceutica Sinica B
Volume15
Issue number2
DOIs
StatePublished - Feb 2025

Keywords

  • Cancer therapy
  • Drug delivery
  • Self-assemble
  • Size-transformation
  • Smart nanomedicine

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics

Fingerprint

Dive into the research topics of 'Size-transformable nanotherapeutics for cancer therapy'. Together they form a unique fingerprint.

Cite this